These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 26968186)
21. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma. Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528 [TBL] [Abstract][Full Text] [Related]
22. [A case of gastric stenosis due to primary gastric malignant lymphoma during administration of R-CHOP]. Tamai Y; Murakami E; Nakamori Y; Mizutani M; Sekine T Gan To Kagaku Ryoho; 2011 Aug; 38(8):1371-3. PubMed ID: 21829084 [TBL] [Abstract][Full Text] [Related]
23. [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab]. Serrano-Navarro I; Rodríguez-López JF; Navas-Espejo R; Pérez-Jacoiste MA; Martínez-González MA; Grande C; Prieto S Rev Esp Enferm Dig; 2008 Nov; 100(11):724-8. PubMed ID: 19159179 [TBL] [Abstract][Full Text] [Related]
24. First case of T-cell/histiocyte-rich-large B-cell lymphoma presenting with duodenal obstruction. Köksal AR; Alkim H; Ergun M; Boga S; Bayram M; Alkim C; Eryilmaz OT Libyan J Med; 2013 Dec; 8(1):22955. PubMed ID: 24345670 [No Abstract] [Full Text] [Related]
25. Relapsed lymphoma mimicking venous ulcer: A case report. Kamal WSA; Affandi AM; Bhullar A; Kamal WSZ Med J Malaysia; 2018 Aug; 73(4):253-254. PubMed ID: 30121690 [TBL] [Abstract][Full Text] [Related]
26. Rare cause of a common symptom: primary cardiac lymphoma. Jandali A; Kabach A; Al Halabi S; Alraies MC Am J Emerg Med; 2015 Dec; 33(12):1849.e5-6. PubMed ID: 25979303 [TBL] [Abstract][Full Text] [Related]
27. DLBCL developed into fatal liver failure during rituximab-containing chemotherapy. Shimazu Y; Nohgawa M J Clin Exp Hematop; 2019; 59(2):93-95. PubMed ID: 31257349 [No Abstract] [Full Text] [Related]
28. What is your diagnosis? Cutaneous B-cell lymphoma. Carlson SW; Aneja S; Honda K; Cooper KD Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456 [No Abstract] [Full Text] [Related]
29. Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP. Ribera JM; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Navarro JT; Feliu E Br J Haematol; 2012 Jun; 157(5):637-9. PubMed ID: 22313456 [No Abstract] [Full Text] [Related]
30. Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy. Walter E; Schmitt T; Dietrich S; Ho A; Witzens-Harig M Leuk Lymphoma; 2012 Nov; 53(11):2290-2. PubMed ID: 22475324 [No Abstract] [Full Text] [Related]
31. Large B-cell non-Hodgkin lymphoma. Vaseemuddin M; Sam R Am J Kidney Dis; 2005 Dec; 46(6):A52, e101-2. PubMed ID: 16315353 [No Abstract] [Full Text] [Related]
33. Patient with high-grade fever, night sweats, and hepatosplenomegaly. Müldür E; Chott A; Mirzaei S; Zojer N; Ludwig H J Clin Oncol; 2011 Apr; 29(10):e254-6. PubMed ID: 21220615 [No Abstract] [Full Text] [Related]
34. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney]. Sagüés M; Paredes V; Altés J; Fernández de Sevilla A Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716 [No Abstract] [Full Text] [Related]
35. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone? George A; Tam CS; Seymour JF Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141 [No Abstract] [Full Text] [Related]
36. FcγRIIA and FcγRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma. Fabisiewicz A; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Siedlecki JA Leuk Lymphoma; 2011 Aug; 52(8):1604-6. PubMed ID: 21657954 [No Abstract] [Full Text] [Related]
37. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma. Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677 [TBL] [Abstract][Full Text] [Related]
38. Modified chop-chemotherapy plus rituximab for diffuse large b-cell lymphoma complicating ataxia-telangiectasia. Rossi G; Zecca M; Marchi A; de Stefano P; Sammarchi L; Locatelli F Br J Haematol; 2003 Jan; 120(2):369-71. PubMed ID: 12542504 [No Abstract] [Full Text] [Related]
39. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma]. Provencio M; Fayad LE Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676 [No Abstract] [Full Text] [Related]